New drug targets in metastatic melanoma.

Abstract excerpt

Over the past 30 years, and despite extensive clinical research, the treatment options for metastatic melanoma have been limited. Single-agent and combination chemotherapy, hormonal therapy, biochemotherapy, immunotherapy, targeted agent therapy and combination regimes have failed to show significant improvement in overall survival. Recent advances and in-depth understanding of the biology of melanoma have...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Skin Neoplasms
• Share to Antineoplastic Agents
• Share to Drug Discovery